4//SEC Filing
Hopper Jonathan Mark 4
Accession 0001140361-25-005658
CIK 0000887359other
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 4:05 PM ET
Size
7.7 KB
Accession
0001140361-25-005658
Insider Transaction Report
Form 4
Vericel CorpVCEL
Hopper Jonathan Mark
Chief Medical Officer
Transactions
- Award
Restricted Stock Unit
2025-02-20+14,000→ 14,000 total→ Common Stock (14,000 underlying) - Award
Stock Option (Right to Buy)
2025-02-20+35,000→ 35,000 totalExercise: $54.31Exp: 2035-02-20→ Common Stock (35,000 underlying)
Footnotes (4)
- [F1]These options shall begin vesting on February 20, 2025 and shall continue to vest and become exercisable in equal quarterly installments over the course of the following four (4) year period.
- [F2]Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation.
- [F3]These RSUs vest in four annual installments with the initial vesting of RSUs granted to the Reporting Person on February 20, 2026. The remaining RSUs will vest in annual installments on February 20, 2027, February 20, 2028, and February 20, 2029, respectively.
- [F4]No expiration date for this type of award.
Documents
Issuer
Vericel Corp
CIK 0000887359
Entity typeother
Related Parties
1- filerCIK 0001626325
Filing Metadata
- Form type
- 4
- Filed
- Feb 23, 7:00 PM ET
- Accepted
- Feb 24, 4:05 PM ET
- Size
- 7.7 KB